ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rotavirus Vaccine Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-34E18122
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rotavirus Vaccine Market Research Report 2024
BUY CHAPTERS

Global Rotavirus Vaccine Market Research Report 2024

Code: QYRE-Auto-34E18122
Report
October 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GlaxoSmithKline Biologicals
Lanzhou Institute of Biological Products
Bharat Biotech
Serum Institute of India

Rotavirus Vaccine Market

The rotavirus vaccine is a vaccine designed to protect against rotavirus, a highly contagious virus that is the leading cause of severe diarrhea and dehydration in infants and young children worldwide. There are two main types of rotavirus vaccines: the monovalent (covering a single strain) and the multivalent (covering multiple strains) versions. Both vaccines contain live, attenuated (weakened) strains of the virus and are administered orally in liquid form.
The global Rotavirus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rotavirus Vaccine include Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccine.
The Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rotavirus Vaccine Market Report

Report Metric Details
Report Name Rotavirus Vaccine Market
Segment by Type
Segment by Application
  • Government Institution
  • Private Sector
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rotavirus Vaccine Market report?

Ans: The main players in the Rotavirus Vaccine Market are Merck, GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products, Bharat Biotech, Serum Institute of India

What are the Application segmentation covered in the Rotavirus Vaccine Market report?

Ans: The Applications covered in the Rotavirus Vaccine Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Rotavirus Vaccine Market report?

Ans: The Types covered in the Rotavirus Vaccine Market report are Monovalent Vaccine, Multivalent Vaccine

Recommended Reports

Human Vaccines

Pediatric Vaccines

Animal Vaccines

1 Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Rotavirus Vaccine by Type
1.2.1 Global Rotavirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Vaccine
1.2.3 Multivalent Vaccine
1.3 Rotavirus Vaccine by Application
1.3.1 Global Rotavirus Vaccine Market Value by Application (2024-2030)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Rotavirus Vaccine Revenue 2019-2030
1.4.2 Global Rotavirus Vaccine Sales 2019-2030
1.4.3 Global Rotavirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rotavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rotavirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rotavirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Rotavirus Vaccine, Date of Enter into This Industry
2.8 Global Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Rotavirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rotavirus Vaccine Market Scenario by Region
3.1 Global Rotavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rotavirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Rotavirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Rotavirus Vaccine Sales by Region: 2025-2030
3.3 Global Rotavirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Rotavirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Rotavirus Vaccine Revenue by Region: 2025-2030
3.4 North America Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rotavirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Rotavirus Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rotavirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Rotavirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Rotavirus Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rotavirus Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Rotavirus Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rotavirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Rotavirus Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rotavirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rotavirus Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rotavirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Rotavirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Rotavirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Rotavirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Rotavirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Rotavirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Rotavirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Rotavirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Rotavirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rotavirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Rotavirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Rotavirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Rotavirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Rotavirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Rotavirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Rotavirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Rotavirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Rotavirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Rotavirus Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline Biologicals
6.2.1 GlaxoSmithKline Biologicals Company Information
6.2.2 GlaxoSmithKline Biologicals Description and Business Overview
6.2.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.3 Lanzhou Institute of Biological Products
6.3.1 Lanzhou Institute of Biological Products Company Information
6.3.2 Lanzhou Institute of Biological Products Description and Business Overview
6.3.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio
6.3.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.4 Bharat Biotech
6.4.1 Bharat Biotech Company Information
6.4.2 Bharat Biotech Description and Business Overview
6.4.3 Bharat Biotech Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bharat Biotech Rotavirus Vaccine Product Portfolio
6.4.5 Bharat Biotech Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Rotavirus Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rotavirus Vaccine Industry Chain Analysis
7.2 Rotavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rotavirus Vaccine Production Mode & Process
7.4 Rotavirus Vaccine Sales and Marketing
7.4.1 Rotavirus Vaccine Sales Channels
7.4.2 Rotavirus Vaccine Distributors
7.5 Rotavirus Vaccine Customers
8 Rotavirus Vaccine Market Dynamics
8.1 Rotavirus Vaccine Industry Trends
8.2 Rotavirus Vaccine Market Drivers
8.3 Rotavirus Vaccine Market Challenges
8.4 Rotavirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
GlaxoSmithKline Biologicals
Lanzhou Institute of Biological Products
Bharat Biotech
Serum Institute of India
List of Tables
 Table 1. Global Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Rotavirus Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Rotavirus Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Rotavirus Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rotavirus Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rotavirus Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Rotavirus Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Rotavirus Vaccine Sales by Region (2019-2024) & (K Units)
 Table 18. Global Rotavirus Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Rotavirus Vaccine Sales by Region (2025-2030) & (K Units)
 Table 20. Global Rotavirus Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Rotavirus Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Rotavirus Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Rotavirus Vaccine Sales by Country (2019-2024) & (K Units)
 Table 27. North America Rotavirus Vaccine Sales by Country (2025-2030) & (K Units)
 Table 28. North America Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Rotavirus Vaccine Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Rotavirus Vaccine Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Rotavirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Rotavirus Vaccine Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Rotavirus Vaccine Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Rotavirus Vaccine Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Rotavirus Vaccine Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Rotavirus Vaccine Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Rotavirus Vaccine Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Rotavirus Vaccine Sales (K Units) by Type (2019-2024)
 Table 51. Global Rotavirus Vaccine Sales (K Units) by Type (2025-2030)
 Table 52. Global Rotavirus Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Rotavirus Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Rotavirus Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Rotavirus Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Rotavirus Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Rotavirus Vaccine Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Rotavirus Vaccine Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Rotavirus Vaccine Sales (K Units) by Application (2019-2024)
 Table 61. Global Rotavirus Vaccine Sales (K Units) by Application (2025-2030)
 Table 62. Global Rotavirus Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Rotavirus Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Rotavirus Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Rotavirus Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Rotavirus Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Rotavirus Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Rotavirus Vaccine Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Rotavirus Vaccine Price (US$/Unit) by Application (2025-2030)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Merck Rotavirus Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GlaxoSmithKline Biologicals Company Information
 Table 76. GlaxoSmithKline Biologicals Description and Business Overview
 Table 77. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. GlaxoSmithKline Biologicals Rotavirus Vaccine Product
 Table 79. GlaxoSmithKline Biologicals Recent Developments/Updates
 Table 80. Lanzhou Institute of Biological Products Company Information
 Table 81. Lanzhou Institute of Biological Products Description and Business Overview
 Table 82. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Lanzhou Institute of Biological Products Rotavirus Vaccine Product
 Table 84. Lanzhou Institute of Biological Products Recent Developments/Updates
 Table 85. Bharat Biotech Company Information
 Table 86. Bharat Biotech Description and Business Overview
 Table 87. Bharat Biotech Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Bharat Biotech Rotavirus Vaccine Product
 Table 89. Bharat Biotech Recent Developments/Updates
 Table 90. Serum Institute of India Company Information
 Table 91. Serum Institute of India Description and Business Overview
 Table 92. Serum Institute of India Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Serum Institute of India Rotavirus Vaccine Product
 Table 94. Serum Institute of India Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Rotavirus Vaccine Distributors List
 Table 98. Rotavirus Vaccine Customers List
 Table 99. Rotavirus Vaccine Market Trends
 Table 100. Rotavirus Vaccine Market Drivers
 Table 101. Rotavirus Vaccine Market Challenges
 Table 102. Rotavirus Vaccine Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rotavirus Vaccine
 Figure 2. Global Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Rotavirus Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Monovalent Vaccine Product Picture
 Figure 5. Multivalent Vaccine Product Picture
 Figure 6. Global Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Rotavirus Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Government Institution
 Figure 9. Private Sector
 Figure 10. Other
 Figure 11. Global Rotavirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Rotavirus Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Rotavirus Vaccine Sales (2019-2030) & (K Units)
 Figure 14. Global Rotavirus Vaccine Average Price (US$/Unit) & (2019-2030)
 Figure 15. Rotavirus Vaccine Report Years Considered
 Figure 16. Rotavirus Vaccine Sales Share by Manufacturers in 2023
 Figure 17. Global Rotavirus Vaccine Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Rotavirus Vaccine Players: Market Share by Revenue in Rotavirus Vaccine in 2023
 Figure 19. Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 22. North America Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 23. United States Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 26. Europe Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Rotavirus Vaccine Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Rotavirus Vaccine Revenue Market Share by Region (2019-2030)
 Figure 34. China Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Rotavirus Vaccine by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Rotavirus Vaccine by Type (2019-2030)
 Figure 53. Global Rotavirus Vaccine Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Rotavirus Vaccine by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Rotavirus Vaccine by Application (2019-2030)
 Figure 56. Global Rotavirus Vaccine Price (US$/Unit) by Application (2019-2030)
 Figure 57. Rotavirus Vaccine Value Chain
 Figure 58. Rotavirus Vaccine Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Live Attenuated Rotavirus Vaccine Market Research Report 2024
Global Rotavirus Vaccines Market Insights Forecast to 2030
Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024
Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Infection Therapeutics Market Research Report 2024
Swine Transmissble Gastroenteritis Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Research Report 2024
Porcine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Infections Drug Market Research Report 2024
Veterinary Vaccine Market
Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Combined Polio Vaccine Market Research Report 2024
Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024
Global Veterinary Vaccination Market Research Report 2025
Global Poliomyelitis Vaccine Market Research Report 2025
Global Viral Vector Vaccine for Humans Market Research Report 2024
Global Veterinary Biological Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions